Deutsche Bank Ag\ Phathom Pharmaceuticals, Inc. Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

A detailed history of Deutsche Bank Ag\ transactions in Phathom Pharmaceuticals, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 20,227 shares of PHAT stock, worth $188,920. This represents 0.0% of its overall portfolio holdings.

Number of Shares

20,227

Previous 15,071 34.21%

Holding current value

$188,920

Previous $155,000 135.48%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$10.25 - $19.5 $52,849 - $100,542	5,156 Added 34.21%	20,227 $365,000
Q2 2024 Aug 14, 2024	BUY	$8.97 - $12.05 $7,256 - $9,748	809 Added 5.67%	15,071 $155,000
Q1 2024 May 15, 2024	SELL	$6.21 - $11.05 $21,343 - $37,978	-3,437 Reduced 19.42%	14,262 $151,000
Q4 2023 Feb 14, 2024	BUY	$6.99 - $10.71 $34,041 - $52,157	4,870 Added 37.96%	17,699 $161,000
Q3 2023 Nov 09, 2023	BUY	$10.26 - $15.7 $17,442 - $26,690	1,700 Added 15.28%	12,829 $133,000
Q2 2023 Aug 14, 2023	SELL	$7.28 - $14.32 $36,909 - $72,602	-5,070 Reduced 31.3%	11,129 $159,000
Q1 2023 May 15, 2023	BUY	$6.19 - $12.36 $33,153 - $66,200	5,356 Added 49.4%	16,199 $115,000
Q4 2022 Feb 13, 2023	BUY	$9.18 - $11.53 $1,395 - $1,752	152 Added 1.42%	10,843 $121,000
Q3 2022 Nov 14, 2022	BUY	$6.46 - $12.11 $3,501 - $6,563	542 Added 5.34%	10,691 $118,000
Q2 2022 Aug 11, 2022	SELL	$6.2 - $15.5 $8,630 - $21,576	-1,392 Reduced 12.06%	10,149 $86,000
Q1 2022 May 13, 2022	SELL	$11.55 - $20.06 $14,991 - $26,037	-1,298 Reduced 10.11%	11,541 $157,000
Q4 2021 Feb 11, 2022	BUY	$17.83 - $33.15 $11,446 - $21,282	642 Added 5.26%	12,839 $253,000
Q3 2021 Nov 04, 2021	SELL	$30.69 - $36.83 $11,416 - $13,700	-372 Reduced 2.96%	12,197 $392,000
Q2 2021 Aug 11, 2021	BUY	$32.66 - $39.87 $168,003 - $205,091	5,144 Added 69.28%	12,569 $425,000
Q1 2021 May 13, 2021	SELL	$33.86 - $48.68 $22,246 - $31,982	-657 Reduced 8.13%	7,425 $278,000
Q4 2020 Feb 16, 2021	BUY	$33.22 - $50.26 $68,798 - $104,088	2,071 Added 34.45%	8,082 $268,000
Q3 2020 Nov 12, 2020	BUY	$29.24 - $40.19 $15,204 - $20,898	520 Added 9.47%	6,011 $220,000
Q2 2020 Aug 13, 2020	BUY	$25.06 - $54.6 $44,631 - $97,242	1,781 Added 48.01%	5,491 $181,000
Q1 2020 May 14, 2020	SELL	$24.65 - $42.83 $5,324 - $9,251	-216 Reduced 5.5%	3,710 $96,000
Q4 2019 Feb 14, 2020	BUY	$18.59 - $37.67 $72,984 - $147,892	3,926 New	3,926 $121,000

Others Institutions Holding PHAT

# of Institutions

144

Shares Held

73.6M

Call Options Held

42.3K

Put Options Held

45.7K

View Full List

About Phathom Pharmaceuticals, Inc.

Ticker PHAT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,175,200
Market Cap $366M
Description
Phathom Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada to vonoprazan, a potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach. It is also develo...

More about PHAT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account